Vaishali Pharma Limited
NSE:VAISHALI.NS
18.75 (INR) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 15.783 | 5.291 | 11.623 | 3.135 | 2.832 | 2.3 | 2.081 | 10.658 | 2.308 | 10.074 | 10.119 | 18.036 |
| Short Term Investments
| 0 | 118.945 | 120.534 | 119.653 | 0 | -32.165 | 3.477 | -3.798 | 2.882 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 15.783 | 124.236 | 11.623 | 3.135 | 2.832 | 2.3 | 2.081 | 10.658 | 2.308 | 10.074 | 10.119 | 18.036 |
| Net Receivables
| 494.274 | 536.205 | 746.34 | 786.96 | 583.891 | 617.589 | 561.708 | 383.442 | 411.838 | 343.629 | 381.97 | 376.395 |
| Inventory
| 3.797 | 30.501 | 6.29 | 5.882 | 8.801 | 9.813 | 18.68 | 11.547 | 33.6 | 33.193 | 81.469 | 53.431 |
| Other Current Assets
| 231.343 | 35.865 | 0 | 16.954 | 601.432 | 0 | 8.038 | 405.02 | 0.594 | 393.588 | 425.961 | 404.435 |
| Total Current Assets
| 745.197 | 726.807 | 764.252 | 812.931 | 613.065 | 629.702 | 590.507 | 427.225 | 448.339 | 436.855 | 517.549 | 475.902 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 14.553 | 17.979 | 9.035 | 9.706 | 11.683 | 8.784 | 9.847 | 11.366 | 13.719 | 16.771 | 6.036 | 1.772 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 8.016 | 8.561 | 7.692 | 2.935 | 3.968 | 4.948 | 3.61 | 0.131 | 1.912 | 0.018 | 0.048 | 0 |
| Goodwill and Intangible Assets
| 8.016 | 8.561 | 7.692 | 2.935 | 3.968 | 4.948 | 3.61 | 0.131 | 1.912 | 0.018 | 0.048 | -0.001 |
| Long Term Investments
| 22.817 | 16.377 | 10.815 | 10.815 | 10.815 | 42.98 | 7.338 | 7.55 | 7.37 | 3.752 | 1.706 | 0.001 |
| Tax Assets
| 1.756 | 1.433 | 1.607 | 1.48 | 1.243 | 1.097 | 1.206 | 0.214 | 1.22 | -3.752 | -1.706 | 0.029 |
| Other Non-Current Assets
| 7.218 | 17.917 | 22.838 | 23.365 | 21.265 | 0 | 30.724 | 0.001 | 25.166 | 4.306 | 10.664 | 8.114 |
| Total Non-Current Assets
| 54.36 | 62.267 | 51.987 | 48.302 | 48.974 | 57.809 | 52.725 | 19.262 | 49.386 | 21.095 | 16.748 | 9.915 |
| Total Assets
| 799.557 | 789.074 | 816.24 | 861.233 | 662.039 | 687.511 | 643.233 | 446.487 | 497.725 | 457.95 | 534.297 | 485.817 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 193.888 | 180.076 | 283.807 | 405.366 | 217.332 | 245.278 | 223.833 | 161.185 | 240.445 | 171.746 | 310.972 | 359.106 |
| Short Term Debt
| 96.576 | 86.272 | 176.676 | 135.904 | 127.761 | 122.967 | 157.498 | 153.767 | 195.552 | 158.273 | 157.661 | 68.144 |
| Tax Payables
| 0 | 19.453 | 12.717 | 3.766 | 0.609 | 7.288 | 4.75 | 3.808 | 0.442 | 0 | 0 | 0 |
| Deferred Revenue
| 27.208 | 23.091 | 43.729 | 28.981 | 44.561 | 50.15 | 4.75 | 6.999 | 11.131 | 1.579 | 2.877 | 2.015 |
| Other Current Liabilities
| 13.148 | 31.341 | 15.157 | 22.354 | 14.502 | 6.388 | 22.855 | 25.933 | 1.913 | 10.422 | 0.158 | 0.023 |
| Total Current Liabilities
| 330.82 | 320.78 | 519.369 | 592.605 | 404.156 | 424.783 | 408.936 | 347.884 | 449.04 | 342.02 | 471.668 | 429.288 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 35.983 | 61.09 | 31.438 | 42.593 | 42.681 | 47.797 | 26.455 | 57.936 | 14.33 | 82.162 | 29.803 | 27.926 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.043 | 1.09 | 0 |
| Other Non-Current Liabilities
| 4.36 | 1.892 | 1.891 | 1.85 | 1.388 | 0.942 | 1.826 | 1.982 | 1.818 | 1.375 | 1 | 0.873 |
| Total Non-Current Liabilities
| 40.343 | 62.982 | 33.329 | 44.443 | 44.069 | 48.739 | 28.281 | 59.918 | 16.148 | 83.58 | 31.893 | 28.799 |
| Total Liabilities
| 371.163 | 383.762 | 552.698 | 637.048 | 448.225 | 473.521 | 437.217 | 407.802 | 465.188 | 425.6 | 503.561 | 458.087 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 328.104 | 0 | 0 | 212.672 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 107.192 | 105.462 | 105.462 | 105.462 | 105.462 | 65.914 | 65.914 | 30 | 5 | 5 | 5 | 5 |
| Retained Earnings
| 149.112 | 141.923 | 75.888 | 35.652 | 25.189 | 24.861 | 17.726 | 9.75 | 27.537 | 27.35 | 25.736 | 22.73 |
| Accumulated Other Comprehensive Income/Loss
| 321.202 | 77.208 | 1.215 | 1.051 | 1.142 | 1.264 | 0.426 | 0 | -0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| -149.112 | -247.385 | 80.976 | 82.021 | -130.651 | 121.95 | 121.95 | -1.065 | 0 | 0 | 0 | 0 |
| Total Shareholders Equity
| 428.394 | 405.312 | 263.542 | 224.186 | 213.814 | 213.99 | 206.016 | 38.685 | 32.537 | 32.35 | 30.736 | 27.73 |
| Total Equity
| 428.394 | 405.312 | 263.542 | 224.186 | 213.814 | 213.99 | 206.016 | 38.685 | 32.537 | 32.35 | 30.736 | 27.73 |
| Total Liabilities & Shareholders Equity
| 799.557 | 789.074 | 816.24 | 861.233 | 662.039 | 687.511 | 643.233 | 446.487 | 497.725 | 457.95 | 534.297 | 485.817 |